Concepedia

Peio Errarte

PE

Statistics

Publications

16

Citations

528

H-Index

13

Active since

2013

Affiliations

BioCruces Health research Institute(Current)

Hospital de Cruces

University of the Basque Country

Ikerbasque

Universidad Europea de Madrid

Peio Errarte is an author at BioCruces Health research Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2013–2023

16

Publications

16

The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

Gorka Larrinaga, Peio Errarte, A.M. Martín et al. · Human Pathology · 2019 · 73 citations

, , +15

The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases

Peio Errarte, Rosa Guarch, Rafael Pulido et al. · PLoS ONE · 2016 · 66 citations · Full text

, , +17

Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

José I. López, Peio Errarte, Asier Erramuzpe et al. · Human Pathology · 2016 · 60 citations

, , +14

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma

Gorka Larrinaga, Jon Danel Solano-Iturri, Peio Errarte et al. · Cancers · 2021 · 44 citations · Full text

, , +17

Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

Peio Errarte, Maider Beitia, Itxaro Pérez et al. · PLoS ONE · 2017 · 42 citations · Full text

, , +17

1–5 of 16